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Three agents which are mitogenic for T lymphocytes (phytohaemagglutinin, monoclonal antibody UCHT 
1 and 12-O-tetradecanoylphorbol-13-acetate) s imulated rapid phosphorylation of a 42 kDa protein in per- 
meabilized T lymphocytes. Phosphorylation occurred on tyrosine and serine residues. A non-mitogenic 
monoclonal antibody (RFTl 1) did not stimulate phosphorylation of this protein. Furthermore, the dose 
response of 42 kDa protein phosphorylation and of mitogenesis to increasing amounts of phytohaemagglu- 
tinin were closely similar. We therefore propose that mitogen-stimulated phosphorylation of the 42 kDa 
protein is part of the mechanism for transduction of mitogenic signals in lymphocytes. To our knowledge, 
this is the first report of rapid, ligand-stimulated tyrosine protein phosphorylation in T lymphocytes. 
T lymphocyte Tyrosine protein kinase Protein kinase C Mitogenesis 
1. INTRODUCTION 
The antigen receptor of T lymphocytes consists 
of two clone-specific disulfide-linked transmem- 
brane glycoprotein chains, (Y and ,8 [ 11. In vivo, the 
binding of antigens (in association with products 
of the major histocompatibility complex genes) 
triggers mitotic activation of specific T lymphocyte 
clones [2]. The receptor-associated T3 complex, 
consisting of three monomorphic transmembrane 
polypeptides, y, 6 and e [3], is also important in the 
transduction of mitogenic signals from the antigen 
receptor to the cell [4]. In vitro, the receptor- 
binding lectin PHA or the monoclonal antibody 
UCHT 1, which binds the T3 complex, are strongly 
mitogenic for T lymphocytes [5,6]. The phorbol 
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Abbreviations: PHA, phytohaemagglutinin; TPA, 
12-O-tetradecanoylphorbol-13-acetate; SDS-PAGE, 
SDS-polyacrylamide gel electrophoresis 
ester TPA, which stimulates protein kinase C 
directly [7], is mitogenic for T lymphocytes, when 
added together with Ca*+ ionophores [8]. 
The cell surface receptors for several growth fac- 
tors (e.g. platelet-derived and epidermal growth 
factors, insulin) possess cytoplasmic domains with 
tyrosine protein kinase activity. Addition of the 
growth factor to membrane preparations carrying 
the appropriate receptor stimulates the tyrosine 
kinase activity [9-l 11. The importance of tyrosine 
phosphorylation in the regulation of proliferation 
is also indicated by the observation that an increase 
in cellular phosphotyrosine content caused by in- 
hibition of phosphotyrosine phosphatases is 
mitogenic for fibroblasts [12]. It is therefore 
believed that phosphorylation of proteins on 
tyrosine residues is a key event in mitogenic signal 
transduction [ 131. Furthermore, tyrosine kinase- 
containing growth factor receptors are down- 
regulated following signal transduction [14-161. 
Although the cytoplasmic domains of the T cell 
receptor and T3 complex proteins are too small to 
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contain kinase activity [ 1,3], we have observed that 
a novel 38 kDa tyrosine protein kinase found in 
the membrane fraction of quiescent T lymphocytes 
is down-regulated following PHA-stimulated 
mitogenesis [ 171, suggesting that tyrosine 
phosphorylation may nevertheless play a role in 
mitotic signalling in lymphocytes. We therefore 
sought evidence for tyrosine phosphorylation of 
proteins in response to stimulation of lymphocytes 
by mitogens. The use of permeabilized cells has 
proved useful in the detection of mitogen- 
stimulated protein phosphorylation [ 18,191 and 
has advantages over the use of isolated mem- 
branes, since this system allows the detection of 
mitogen-stimulated events which are dependent on 
interactions between cytoplasmic and membrane- 
bound proteins [18]. We have therefore used 
permeabilized lymphocytes and the results show 
that three different mitogens stimulate the 
phosphorylation of a 42 kDa protein on both 
tyrosine and serine residues. 
2. MATERIALS AND METHODS 
PHA was from Wellcome Reagents, and TPA 
from Sigma. Monoclonal antibody UCHT 1 was 
kindly given by Drs Peter Beverley and Kieran 
O’Flynn and RFTl 1 by Professor George Janossy 
and Dr Dario Campana. 
Quiescent lymphocytes were obtained from the 
peripheral blood of healthy volunteers and freed of 
monocytes and platelets. Protein phosphorylation 
was detected by permeabilizing the lymphocytes 
with a brief treatment with lysolecithin followed by 
incubation with [y-‘*P]ATP in the buffer system 
detailed elsewhere [ 181. Following labelling (usual- 
ly for 3 min) cells were fractionated into Nonidet 
P-40 soluble and insoluble fractions and analyzed 
by SDS-PAGE under reducing conditions. 
Phosphorylated proteins were identified by 
autoradiography of dried gels. These procedures 
have been previously described in detail [18]. 
Autoradiograms were scanned using a Joyce-Loebl 
Chromoscan equipped with an electronic integra- 
tion facility. 
Phosphoamino acid analysis was carried out by 
hydrolyzing individual labelled protein bands in 
6 N HCl followed by high voltage paper elec- 
trophoresis in 7% formic acid, pH 1.7 [20]. 
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Fig. 1. Mitogen stimulated phosphorylation f a 42 kDa 
protein in permeabilized lymphocytes. Lymphocytes 
were permeabilized and labelled with [y-32P]ATP. 
Nonidet P-40 soluble (A) and insoluble (B) fractions 
were analyzed by SDS-PAGE and autoradiography. 
Lanes: 1, no additions; 2, plus 2,ul RFTll; 3, plus 1~1 
PHA; 4, plus 5 pl TPA (1 PM); 5, plus 2 pl UCHT 1. 
Figures indicate molecular masses of marker proteins in 
kDa. The filled triangle indicates the position of the 
42 kDa protein. 
3. RESULTS 
Permeabilized lymphocytes were labelled with 
[y-32P]ATP in the presence or absence of PHA and 
the Nonidet P-40 soluble protein fraction analyzed 
4 I 
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Fig.2. Time course of PHA-stimulated phosphorylation 
of the 42 kDa protein. Permeabilized lymphocytes were 
labelled with [Y-~~P]ATP. Curves: A, no addition; B, 
1~1, PHA added, 2 min incubation; C, 1~1 PHA 
added, 5 min incubation. The Nonidet P-40 soluble 
fraction was analyzed by gel electrophoresis. 
Densitometric scans of the relevant region of the 
autoradiograms are shown. Molecular masses of the 
bands are shown in kDa. 
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PHA] (~1 id) 
by SDS-PAGE. The phosphorylation of a 42 kDa 
protein was markedly stimulated by the addition of 
PHA (fig.lA, lanes 1 and 3). Two other agents 
which are also mitogenic for T lymphocytes, the 
monoclonal antibody UCHT 1 and the phorbol 
Fig.3. Dose response of the 42 kDa protein 
phosphorylation and [3H]thymidine incorporation to 
increasing concentrations of PHA. Permeabilized 
lymphocytes were labelled with [y-32P]ATP in the 
presence of increasing concentrations of PHA. Nonidet 
P-40 soluble fractions were analyzed by gel 
electrophoresis. Autoradiograms were scanned, and 
areas under the 42 kDa peak assessed by integration 
(0). The mitogenic response of lymphocytes to 
increasing concentration of PHA was estimated by 
measuring the incorporation of [3H)thymidine 3 days 
following mitogen addition (0) (mean of triplicate 
determinations). 
ester TPA, also stimulated the phosphorylation of 
a 42 kDa protein (fig.lA, lanes 4 and 5). Identical 
results were obtained in fourteen consecutive ex- 
periments. By contrast, the non-mitogenic 
monoclonal antibody RFTl 1 (which binds the Tl 1 
glycoprotein on the lymphocyte surface) did not 
stimulate 42 kDa protein phosphorylation (fig. lA, 
lane 2). 
Fig.4. Phosphoamino acid analysis of 42 kDa bands. Individual 42 kDa bands from Nonidet P-40 soluble (lanes l-3) 
and insoluble (lanes 4-6) lymphocyte fractions were excised from gels, and the composition of labelled phosphoamino 
acids was analyzed as described in section 2. Ori, origin; PThr, phosphothreonine; PTyr, phosphotyrosine; PSer, 
phosphoserine. Lanes: 1,4, plus 1~1 PHA; 2,5, plus 5 ~1 TPA (1 PM); 3.6, plus 2 ~1 UCHT 1. 
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Stimulation of the 42 kDa protein phos- 
phorylation by PHA was rapid, being maximal 
within 2 min of addition of PHA (fig.2). Further- 
more, the dose response of PHA-stimulated 
phosphorylation closely paralleled the mitogenic 
response of intact lymphocytes to PHA, as 
measured by the incorporation of [3H]thymidine 
into DNA (fig.3), strongly suggesting that this 
phosphorylation event was an important part of 
the mitogenic signalling mechanism initiated by 
PHA. In an attempt to characterize the 42 kDa 
protein, we initially studied its subcellular localiza- 
tion. Although this phosphorylated protein was in- 
itially detected in the Nonidet P-40 soluble fraction 
of labelled lymphocytes (fig. 1 A), the phosphoryla- 
tion of this protein was also clearly observed by 
electrophoretic analysis of Nonidet P-40 resistant 
cytoskeletal material from permeabilized cells 
which were labelled in the presence of PHA, 
UCHT 1 or TPA (fig.lB, lanes 1,3,4 and 5). This 
suggested that the 42 kDa protein was at least par- 
tially associated with the detergent resistant 
cytoskeletal material of the cell. The non- 
mitogenic antibody RFTll did not stimulate 
phosphorylation of this protein (fig.lB, lane 2). 
We further characterized the 42 kDa protein 
phosphorylation by identifying the amino acids on 
which it was phosphorylated. Fig.4 shows that the 
protein was phosphorylated approximately equally 
on tyrosine and serine residues in response to 
PHA, UCHT 1 or TPA stimulation. Furthermore, 
the identical amino acid specificity of 
phosphorylation was observed with all three 
mitogens and whether the protein analyzed was ob- 
tained from either the Nonidet soluble or insoluble 
cell fraction (fig.4). 
4. DISCUSSION 
The results here show that three different agents 
which are mitogenic for T lymphocytes in vitro, 
stimulated rapid phosphorylation of a 42 kDa pro- 
tein on tyrosine and serine residues when added to 
permeabilized cells in the presence of [y-32P]ATP. 
We suggest that this phosphorylation event is im- 
portant in transduction of mitogenic signals, since 
it was elicited by three mitogens of completely dif- 
ferent classes (a lectin, a monoclonal antibody and 
a phorbol ester) but not by the non-mitogenic 
monoclonal antibody RFTI 1. The similarity of the 
56 
dose-response curves for PHA-stimulated protein 
phosphorylation and for PHA-stimulated mito- 
genesis reinforces this conclusion. 
Rapid tyrosine phosphorylation of 42 kDa pro- 
teins in response to treatment of mouse [21,22], 
chick [23,24] and human [24] fibroblasts by a 
variety of growth stimulatory agents has been 
reported. Although direct evidence implicating this 
phosphorylation in the mitogenic response has not 
been obtained, the observation that this 
phosphorylation was elicited by different natural 
growth factors and other mitogenic agents uggests 
that tyrosine phosphorylation of the 42 kDa pro- 
tein plays an important role in mitosis [22]. We are 
currently attempting to characterize the 42 kDa 
tyrosine phosphorylated protein of lymphocytes in 
order to evaluate its relationship to the 42 kDa 
proteins described in fibroblasts. 
We have recently employed a quantitative im- 
munoassay using an antiphosphotyrosine antibody 
to demonstrate that the content of phospho- 
tyrosine in cellular proteins increased three-fold 
when intact lymphocytes were stimulated with 
PHA for 10 min (Hall, B. et al., in preparation). 
This data, taken together with work from other 
laboratories which suggest that protein tyrosine 
phosphorylation is a key event in mitogenic signal 
transduction in non-lymphoid cells [g-13,21-24] 
strongly support the view that similar mechanisms 
operate in T lymphocytes. 
Subcellular distribution studies indicated that 
the 42 kDa protein is partially associated with the 
detergent-resistant cytoskeleton of the lym- 
phocyte. It is therefore of interest that the recep- 
tors for epidermal growth factor [25] and nerve 
growth factor [26] are also associated with this 
structure. Furthermore the intrinsic tyrosine kinase 
activity of the epidermal growth factor receptor 
was shown to phosphorylate cytoskeletal proteins 
in a ligand-stimulated reaction in vitro [25]. 
The 42 kDa protein is unlikely to be a compo- 
nent of the antigen receptor, since the polypeptide 
chains of the receptor have molecular masses in ex- 
cess of 50 kDa [l] and do not contain any tyrosine 
residues in their cytoplasmic domains [27]. The 
polypeptide chains of the T3 complex are also 
ruled out, since their molecular masses are below 
30 kDa [l]. Therefore, the 42 kDa protein may be 
a novel component of the T lymphocyte mitogenic 
signalling mechanism. 
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Although the experiments described here point [33,34]. The observations described here, together 
strongly to a crucial role for tyrosine phosphoryla- with the additional evidence for the involvement of 
tion in mitogenic signalling in lymphocytes, we are kinase C in the mitogenic response of T lym- 
uncertain as to the identity of the enzyme catalyz- phocytes, suggest that a cascade of biochemical 
ing this event. We have previously observed that a events, initiated by the breakdown of inositol- 
38 kDa membrane-bound tyrosine kinase found in containing lipids and involving subsequent protein 
quiescent T lymphocytes is down-regulated follow- phosphorylation events, may be important in the 
ing PHA-stimulated entry into the cell cycle [ 171. activation of T lymphocytes. However, inositol 
Separation of cell extracts by gel filtration has lipid breakdown also generates inositol 1,4,5- 
shown that this enzyme is the predominant trisphosphate [7] which causes an increase in 
tyrosine kinase in lymphocytes (Hall, B. et al., in cytoplasmic Ca*+ [35] by stimulating release of 
preparation). However, we and others have also Ca*+ from intracellular stores [36]. This increase in 
described a 55-60 kDa tyrosine kinase in par- cytoplasmic Ca*+ is also an essential component of 
ticulate fractions from normal [17,28] and malig- the mitogenic response of lymphocytes [37]. The 
nant [29] lymphoid cells. The cDNA encoding this manner in which Ca*+-mediated events and protein 
enzyme has been cloned and its gene has been phosphorylation events synergize to secure com- 
shown to be preferentially expressed in lymphoid mitment to mitosis remain unclear. The identifica- 
tissues [30]. Although the level of the 55-60 kDa tion of tyrosine protein kinases and their substrates 
enzyme did not appear to vary during the lym- which are phosphorylated in response to mitogen 
phocyte cell cycle [17] we cannot exclude a role for stimulation will contribute to the unravelling of the 
this kinase in catalyzing the mitogen-stimulated complex pathways of mitogenesis in T lym- 
phosphorylation described here. phocytes. 
Since TPA activates protein kinase C directly 
[7], stimulation of tyrosine phosphorylation by 
TPA suggests that initial stimulation of protein 
kinase C activates a tyrosine kinase which 
phosphorylates in turn the 42 kDa protein. (Kinase 
C itself does not phosphorylate tyrosine residues 
[7].) TPA, which is mitogenic for fibroblasts, also 
stimulated tyrosine phosphorylation of a 42 kDa 
protein in these cells [22,24,30]. TPA treatment of 
the human promyelocytic leukaemia cell line 
HL60, which stimulates differentiation to 
macrophages, also stimulated tyrosine phos- 
phorylation of a 42 kDa protein [31]. These 
authors have also proposed a mechanism whereby 
activation of kinase C activates in turn a tyrosine 
kinase [22,31]. However, as in the present work, 
the identity of the tyrosine kinase involved and the 
mechanism of its activation by kinase C remain 
unknown. 
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